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DURING EVOLUTION, AN INTEGRATED SYSTEM regulating substrate storage and utilization at the whole organism level has been developed by means of nutrient and energy sensors that constantly gauge the change in metabolic or environmental conditions (36) . One example is the decrease in glycogen storage observed during fasting, which is associated with a concomitant shift in substrate utilization from carbohydrate to lipid oxidation, aiming to preserve glucose for use by the brain and maintain whole body energy homeostasis (45) .
As a metabolically flexible tissue, skeletal muscle contributes to a large extent to this whole body metabolic adaptation that occurs through complex and coordinated regulation of several energy/nutrient-sensing pathways (14) . Among them, the serine/threonine AMP-activated protein kinase (AMPK) is considered one of the main sensors of energy depletion. Once activated, AMPK acts to restore energy balance by switching off energy-consuming pathways and promoting ATP-generating processes (7, 28, 46) . AMPK consists of a heterotrimeric complex containing a catalytic ␣-subunit and two regulatory ␤-and ␥-subunits. Phosphorylation of the ␣-subunit at Thr 172 by upstream AMPK kinases such as the liver kinase B or calmodulin-dependent protein kinase kinase-␤ is required for AMPK activation. The ␤-subunit acts as a scaffold to which the two other subunits are bound and contains a carbohydrate-binding site that allows AMPK to sense energy reserves in the form of glycogen (7, 28, 46) . When cellular energy status is threatened, the binding of AMP and/or ADP to the ␥-subunit activates AMPK via a complex mechanism involving direct allosteric activation, phosphorylation on Thr 172 by AMPK kinases, and inhibition of dephosphorylation by protein phosphatase(s) (7, 28, 46) . Interestingly, studies in rodents suggest that skeletal muscle AMPK activation occurs rapidly during fasting (13) , triggering the transcriptional modulation of genes involved in lipid and glucose metabolism (6) .
Other energy/nutrient-sensing pathways, such as the mammalian target of rapamycin (mTOR) (52) , some forkhead protein (FoxO) family members (25) , sirtuin 1 (SIRT1) (22) , and the class IIa histone deacetylase 4 (HDAC4) (40) , were also suggested to be involved in the metabolic shift toward lipid oxidation during fasting in peripheral tissues. Interestingly, all of these pathways are tightly interconnected with AMPK (4, 30, 39) , suggesting that the kinase could play a central role in skeletal muscle metabolic flexibility.
Modulation of energy/nutrient-sensing pathways is likely to be involved in health and diseases. Indeed, calorie restriction was shown to extend lifespan and delay the onset of age-related diseases in a wide spectrum of organisms (20) , partly by inducing acute and long-lasting changes in energy/nutrientsensing signaling pathways (9, 24, 34, 59) . Therefore, a better understanding of the energy/nutrient-sensing machinery in humans would provide important insight into the pathophysiology of various age-related diseases, including type 2 diabetes and cancer. To the best of our knowledge, there is currently no data available reporting the kinetic of response of whole body substrate oxidation rates and skeletal muscle energy/nutrientsensing pathways in humans during fasting. Therefore, the purpose of the present study was to investigate how short-term fasting affects whole body energy homeostasis and skeletal muscle energy/nutrient-sensing pathways and transcriptome in healthy humans.
MATERIALS AND METHODS
Ethical approval. The present study (Clinical Trial Registration No. NCT01387919) was approved by the Medical Ethics Committee of the Leiden University Medical Center and performed in accordance with the principles of the revised Declaration of Helsinki. All volunteers gave written, informed consent before participation.
Subjects. Twelve lean male volunteers (body mass index 21.3 Ϯ 0.6 kg/m 2 , age 22 Ϯ 1 yr) were included. All of them were healthy, weight-stable, nonsmoking Caucasians with a fasting plasma glucose of Յ5.6 mmol/l and without family history of diabetes. Height, weight, and body mass index were measured according to World Health Organization recommendations.
Study design. All participants were instructed not to perform physical activity during the last 48 h before the study day and were admitted to our research center after an overnight fast. The intervention study was started after a standardized breakfast (t ϭ 0; 2 slices of brown bread with cheese, 300 calories), followed by 24 h of fasting. Water and caffeine-free tea were allowed ad libitum, whereas physical activity was restricted (with the exception of short walks). Blood samples were taken after breakfast (postmeal, t ϭ 90 min) and after 10 and 24 h of fasting by the means of an intravenous cannula, which was inserted in the elbow just before breakfast. Muscle biopsies from musculus vastus lateralis were collected after breakfast (baseline, t ϭ 105 min) and after 10 and 24 h of fasting under localized 1% lidocain anesthesia, as described previously (43) .
Indirect calorimetry. Subjects were placed under the ventilated hood after ϳ75 min, 10 h, and 24 h of fasting (OxyconPro, Mijnhardt Jaegher, The Netherlands). Respiratory quotient and substrate oxidation were calculated from CO 2 and O2 concentrations in the exhaled air, as described previously (32) .
Laboratory analysis. Serum glucose, total cholesterol, triglycerides, free fatty acids, alkaline phosphatase, and creatinine were measured on a Modular Analytics P-800 system (Roche Diagnostics). Serum insulin and insulin-like growth factor I were measured by immunoluminometric assay on an Immulite 2500 automated system (Siemens Healthcare Diagnostics). Cortisol, free T 4, and thyroidstimulating hormone were measured by electrochemoluminescence immunoassay on a Modular Analytics E-170 system (Roche Diagnostics). Triiodothyronine was measured by fluorescence polarization immunoassay on an AxSym system (Abbott Laboratories, North Chicago, IL). Growth hormone was measured by immunofluorometric assay (Wallac). Serum active ghrelin, leptin, and adiponectin were determined by radioimmunoassay (Millipore). Testosterone was determined by a direct RIA (Siemens Healthcare Diagnostics), and sex hormone-binding globulin was measured on an automated Immulite 2500 (Siemens, Breda, The Netherlands). Ketone bodies were measured using test strips on the Precision Xtra Blood Glucose and Ketone Monitoring System (Abbott Laboratories).
Western blot. Skeletal muscle biopsies (ϳ30 -45 mg) were homogenized by Ultra-Turrax (22,000 rpm, 2 ϫ 5 s) in a 6:1 (vol/wt) ratio of ice-cold buffer containing 5 mM HEPES (pH 7.6), 50 mM NaF, 50 mM KCl, 5 mM NaPPi, 1 mM EDTA, 1 mM EGTA, 5 mM ␤-GP, 1 mM Na 3VO4, 1 (47) . AMPK activity. AMPK heterotrimeric complexes were immunoprecipitated from 500 g of muscle lysate using protein A-agarose beads (GE Healthcare) and a pan ␣-specific AMPK antibody (Santa Cruz Biotechnology) incubated together at 4°C overnight on a rotating wheel. The AMPK activity was measured in the immunoprecipitate by radioactive assay, using [␥-
32 P]ATP as described previously (57) . RNA isolation. Total RNA was isolated from skeletal muscle biopsies (ϳ25-30 mg) using the phenol-chloroform extraction method (Tripure RNA Isolation reagent; Roche), treated with the TurboDNAse kit according to the manufacturer's protocol (TurboDNAse; Life Technologies), and quantified by NanoDrop (ND1000; Thermo Scientific). The quality and integrity of RNA was tested using 2100 Bioanalyzer (Agilent Technologies, Waldbronn, Germany), and all the samples had a RNA integrity number score of Ͼ8.
Microarray and real-time RT-PCR. For microarray analysis, Illumina TotalPrep-96 RNA Amplification kit was used to generate biotin-labeled, amplified cRNA starting from 200 ng of total RNA. Seven-hundred fifty nanograms of the obtained biotinylated cRNA samples for each subject and time points were hybridized onto the Illumina HumanHT-12 v4 BeadChip array. Primary gene expression analysis of the scanned BeadChip arrays was performed using Illumina's Genomestudio version 2011.1. Analysis was performed with the lumi package version 2.4.0 in R (18) . Data were subjected to a variance-stabilizing transformation function and subjected to quantile normalization. The difference relative to the postmeal (baseline) condition was calculated from the mean normalized intensities for each condition, assuming a log2 scale, and fold change were calculated after back transformation to the linear scale. The significance of difference in gene expression relative to the postmeal condition was calculated from a hierarchical linear model, as implemented in the limma package version 3.8.3, with expression as dependent variable and time point and individual as categorical independent variables. The fold change vs. postmeal condition was calculated as the absolute ratio of normalized intensities between the mean values of all individual fold changes (postmeal/10 or 24 h of fasting). Two cutoff values were used to select the regulated genes and minimize the chances of false positives: fold changes Ͼ1.25 and P Յ 0.05 (upregulated) and fold changes Ͻ0.75 and P Յ 0.05 (downregulated). The gene lists of interest were next generated and analyzed for enriched gene ontology (GO) terms for biological processes, molecular functions, protein classes, and pathways using the Web-based software PANTHER 8.1 (37) . The microarray data have been deposited in the NCBI Gene Expression Omnibus repository under no. GSE55924. For real-time RT-PCR, first-strand cDNA was synthesized from 1 g of total RNA using a Superscript first-strand synthesis kit (Invitrogen). Real-time PCR assays were performed using specific primer sets (sequences provided on request) and SYBR Green on a StepOne Plus Real-time PCR system (Applied Biosystems). mRNA expression was normalized to ribosomal protein S18 (Rps18) and expressed as mean log2 change vs. postmeal group.
Statistical analysis. All data are presented as means Ϯ SE. A mixed model was used to compare all measurements during fasting with the baseline (postmeal) values: time was modeled as fixed effect, whereas random intercepts were used to model the subject-specific deviation from the mean. Within each analysis, a Bonferroni post hoc test was used to adjust for multiple comparisons. All of the statistical analyses were performed using SPSS 18.0 for Windows (SPSS).
RESULTS

Effects of fasting on body weight and metabolic parameters.
The anthropometric and metabolic characteristics of the subjects were determined at baseline (postmeal, ϳ90 min after a standardized breakfast of 300 kcal) and after 10 and 24 h of fasting (Table 1) . Body weight decreased upon fasting (Ϫ1.9%, P Ͻ 0.05). As expected, a significant time-dependent decrease in plasma insulin, leptin, and triiodothyronine levels was observed, whereas circulating growth hormone, free fatty acid, ketone bodies, cortisol, alkaline phosphatase, and creatinine increased (Table 1) .
Effects of fasting on whole body glucose and lipid oxidation rates. The substrate oxidation rates were determined by indirect calorimetry at baseline and after 10 and 24 h of fasting ( Table 2 ). The resting energy expenditure, either expressed as absolute or corrected for lean body mass, remained unaffected throughout the fasting period. As expected, fasting led to a significant decrease in respiratory quotient, indicating a shift in substrate metabolism from glucose toward lipid oxidation (Ϫ48% and ϩ702% after 24 h, respectively, P Ͻ 0.05).
Effect of fasting on insulin/mTOR complex 1 signaling pathways in human skeletal muscle. The protein expression and phosphorylation state of key molecules involved in the insulin/ mTOR signaling pathway were determined in skeletal muscle biopsies at baseline and after 10 and 24 h of fasting ( Fig. 1 ). Tubulin expression, used as a housekeeping protein, as well as PKB␣/␤, Akt substrate of 160 kDa (AS160), mTOR, 4E-binding protein-1 (4E-BP1), S6, ERK1/2, and cAMP response element-binding protein (CREB) were not affected no matter what the conditions (Fig. 1A and data not shown). Although the IR␤ expression remained unaltered (Fig. 1B) , the phosphorylation of both PKB (also called Akt) and its downstream target AS160 was reduced significantly in response to fasting (Fig. 1 , C and D), in line with the time-dependent decrease in plasma insulin levels. In addition, the phosphorylation state of mTOR on its Ser 2448 residue was lowered by fasting ( Fig. 1E) , together with phosphorylation of mTOR complex 1 (mTORC1) downstream targets ribosomal protein S6 kinase/S6 and eukaryotic initiation factor 4E-BP1 (Fig. 1, F and G) . By contrast, fasting induced a time-dependent increase in both extracellular signal-regulated kinase (ERK) and CREB phosphorylation on their respective regulatory residues ( Fig. 1, H and I) .
Effect of fasting on AMPK expression and signaling in human skeletal muscle. We next assessed whether fasting affects the protein expression, phosphorylation state, and activity of AMPK. As shown in Fig. 2 , A and B, neither AMPK phosphorylation on its activating Thr 172 residue nor AMPK␣ protein expression differed from baseline after 10 and 24 h of fasting. Therefore, the stoichiometry of AMPK-Thr 172 phosphorylation assessed by the phosphorylated-to-total protein ratio was not affected during fasting (Fig. 2C ). This was confirmed by unchanged AMPK activity measured by kinase assay (0.38 Ϯ 0.02, 0.39 Ϯ 0.02, and 0.43 Ϯ 0.03 mU/mg protein at baseline, 10 h, and 24 h of fasting, respectively). Surprisingly, the phosphorylation state of ACC on Ser 221 , one of the main AMPK downstream targets, was found to be significantly decreased during fasting, whereas the expression of ACC was not affected (Fig. 2, C and D) . The stoichiometry of ACC-Ser 221 phosphorylation, i.e., the phosphorylated-tototal ratio, followed the same pattern, although it did not reach significance (Ϫ23% at 24 h, P ϭ 0.17; Fig. 2E ). Of note, the mRNA expression of the AMPK upstream kinases liver kinase B and Ca 2ϩ /calmodulin-dependent protein kinase kinase-␣/␤ and of the different isoforms of AMPK catalytic ␣-and regulatory ␤-and ␥-subunits did not change during fasting, except for the AMPK␥3 isoform that was significantly lowered after 24 h compared with baseline (data not shown).
Effect of fasting on FoxO1 and SIRT1/HDAC4 histone deacetylases in skeletal muscle. In addition to the insulin/ mTOR and AMPK pathways, other energy/nutrient-sensing pathways, such as FoxO1 (25), SIRT1 (22) , and HDAC4 (40), were also suggested to be involved in the regulation of skeletal muscle substrate metabolism. Therefore, the fasting-induced changes in skeletal muscle expression and phosphorylation state of these proteins were determined. The phosphorylation of Thr 24 -FoxO1 was significantly reduced in response to fasting (Fig. 3A) . Intriguingly, total FoxO1 protein levels were also decreased, leaving the stoichiometry of phosphorylation unaffected and suggesting fasting-induced change in subcellular localization of the protein (Fig. 3, B and C) . The phosphorylation and content of SIRT1 followed the same pattern as FoxO1, i.e., a decrease in response to fasting, although it did not reach significance (Fig. 3, D-F) . Furthermore, the phosphorylation of Ser 632 -HDAC4, but not the protein content, was found to be transiently reduced in skeletal muscle after 10 h of fasting (Fig. 3, G-I) .
Effect of fasting on mitochondrial content in skeletal muscle. Since modulation of nutrient-sensing pathways, including mTOR, AMPK, and SIRT1, is linked to regulation of mitochondrial biogenesis, the protein expression of citrate synthase (CS) and of several mitochondrial respiratory chain complex subunits was determined in skeletal muscle. However, no differences in the expression of these classical markers used for assessing mitochondrial tissue content were observed in response to short-term fasting (Fig. 4) .
Effect of fasting on skeletal muscle transcriptome. Gene expression profiling was carried out to gain insight into the mechanisms of the adaptive processes that take place in skeletal muscle during fasting (Fig. 5) . Among the 34,696 genes present on the microarray (47,323 transcripts), we found that 12,410 (36%) were expressed in skeletal muscle in at least one of the samples. Using a detection P value threshold of 0.05 and a log2 mean fold change Ͻ0.75 or Ͼ1.25, a total of 44 (24 upregulated and 20 downregulated) and 901 (432 upregulated and 469 downregulated) differentially expressed genes (DEGs) from baseline were identified after 10 and 24 h of fasting, respectively. Analysis of the overlapping DEGs revealed that only 23 genes were significantly affected by fasting at both time points. Microarray data validation of genes selected among the top regulated ones (Table 3 ) was performed using real-time quantitative PCR, confirming the significant changes observed for all the genes tested (Table 4) . Finally, to gain insight into the biological implication of the observed transcriptional changes after 10 and 24 h of fasting, the significant DEGs were analyzed for overrepresented GO terms using the PANTHER software. Interestingly, the GO annotations found to be significantly overrepresented in both gene sets revealed that most of the biological categories identified belonged to the regulation of metabolic processes, although no specific related pathways were identified (Table 5 ). Of note, the GO term "primary metabolic process" was found to be the only one significantly overrepresented in the gene set constituted by the 23 overlapping DEGs (P ϭ 0.0085; data not shown) compared with the human skeletal muscle transcriptome.
DISCUSSION
In the present study, we investigated the time-dependent effects of fasting on whole body glucose/lipid oxidation rates in relation to changes in energy/nutrient-sensing pathways and gene expression in skeletal muscle from healthy men. To our knowledge, this is the first study to provide a comprehensive map of the main signal transduction pathways as well as transcriptomic changes occurring in human skeletal muscle during short-term fasting that participate in the coordinated adaptation of whole body substrate metabolism.
In healthy individuals who exhibit a high degree of metabolic flexibility, the adaptation to short-term fasting is characterized by a rapid decrease in glucose oxidation associated with a concomitant increase in lipid oxidation by peripheral tissues, mostly in skeletal muscle (45) . In our cohort of lean young men, we observed this expected fasting-induced shift in whole body substrate metabolism, together with a decrease in plasma levels of insulin and leptin, and simultaneous increase in ketone bodies, free fatty acids, and growth hormone levels, as reported previously (10, 56) . In line with the decrease in circulating insulin levels, we found that the phosphorylation state of (Akt)/PKB was reduced by fasting in skeletal muscle, whereas the protein expression of both IR␤ and PKB was not affected. Moreover, the phosphorylation of AS160, one of the main PKB downstream targets, which is involved together with TBC1D1 in the insulin-mediated translocation of the glucose transporter 4 from intravesicular pool to plasma membrane (38) , was similarly diminished. These findings are in line with our previous report in lean individuals subjected to prolonged (48 h) fasting (57) and may suggest that part of the fastinginduced shift from whole body glucose toward lipid oxidation is secondary to an early reduction of insulin-mediated glucose uptake by skeletal muscle. Of note, Soeters et al. (44) did not find significant differences in PKB and AS160 phosphorylation in skeletal muscle from healthy individuals when comparing 14 with 62 h of fasting, which was most likely due to the fact that the inhibition of the pathway was already maximal after 14 h, as shown in the present study. The increase in ERK phosphorylation observed during fasting might be the consequence of the elevated plasma level of growth hormone, which has been shown to promote ERK phosphorylation in skeletal muscle by a growth hormone receptor/Janus kinase 2-mediated pathway (8) . Interestingly, ERK was reported to promote both CD36-mediated fatty acid uptake (51) and hormone-sensitive lipasestimulated lipolysis (16) in rodent skeletal muscle, suggesting that activation of this pathway might be involved in the fasting-induced shift from glucose toward FA oxidation.
AMPK is a cellular energy sensor, located at the crossroads of several metabolic pathways, that acts as a master regulator of energy balance. Once activated, AMPK increases insulinindependent glucose uptake, promotes lipid oxidation, and enhances mitochondrial biogenesis in skeletal muscle through direct phosphorylation of key regulatory enzymes or transcription factors (27, 54) . Since previous studies in rodents have shown that skeletal muscle AMPK is activated in response to fasting (13), we investigated whether the AMPK pathway was also affected in humans. In the present study, we did not find any differences in skeletal muscle AMPK expression, phosphorylation, or activity after 10 and 24 h of fasting compared with the baseline (postmeal) condition. In line with this finding, Vendelbo et al. (53) reported recently that long-term fasting (72 h) did not affect AMPK activity in healthy individuals. Furthermore, AMPK activity was apparently not affected by feeding or fasting in skeletal muscle from neonatal pigs (48) . However, as already discussed elsewhere (57), we cannot exclude that AMPK activation in response to fasting could constitute an early and transient event occurring during the very first hour following food deprivation. In addition, although partly counterintuitive, the increase in circulating FFA levels during fasting might play a role in the regulation of skeletal muscle AMPK, as suggested previously by de Lange et al. (13) for explaining why AMPK activity returned back to basal after 12 h of fasting in rat skeletal muscle. Therefore, additional experiments that include earlier time points are required to clarify this issue. Of note, we also observed some discrepancies between AMPK and ACC phosphorylation during fasting, as reported previously in human skeletal muscle during exercise (58) . Indeed, we found a trend for a decrease in Ser 221 -ACC phosphorylation, although AMPK activity was not affected. Among possible explanations, early studies have reported that phosphorylation of ACC by PKA can interfere sterically with phosphorylation by AMPK on its targeted residue located nearby (12) . Although speculative, fasting may affect the regulation of ACC phosphorylation by AMPK though activation of PKA, in line with the increased phosphorylation of the PKA downstream target CREB observed in our conditions (Fig. 1I) . Taken together, this also indicates that changes in skeletal muscle ACC phosphorylation (and presumably activity) seem not to be a major determinant involved in the metabolic shift from whole body carbohydrate toward lipid oxidation during fasting.
Another important component in the energy and nutrientsensing pathways is the mTOR, a kinase that integrates both intracellular and extracellular signals and serves as a central regulator of cell metabolism, growth, proliferation, and survival (35) . The mTORC1, which is one of the two protein complexes containing mTOR, plays an important role in coordinating anabolic and catabolic processes in response to growth factors and nutrients (35) . In response to fasting, we found that phosphorylation of skeletal muscle mTOR and mTORC1 downstream targets S6K/S6 and 4E-BP1 were reduced, an effect that is likely due to reduced PKB signaling. Indeed, active PKB promotes mTORC1 action by phosphorylating and inactivating proline-rich Akt substrate of 40 kDa and tuberous sclerosis protein 2 (TSC2) (35) . AMPK can also inhibit mTOR signaling by direct phosphorylation of either TSC2 (31) or raptor (26) , but the kinase is not likely to be involved in our condition, as its activity was not affected in response to fasting. On top of negatively regulating protein synthesis, one of the most ATP-consuming pathways, mTORC1, controls the transcriptional activity of PPAR␥ coactivator-1 (PGC-1␣), a nuclear cofactor that regulates mitochondrial biogenesis and oxidative metabolism (11) . Although PPARGC1A (the gene encoding PGC-1␣) was among the most extensively downregulated transcripts after 24 h of fasting, we did not find any obvious differences in other key genes involved in mitochondrial biogenesis or in the skeletal muscle protein contents of either CS or the main respiratory chain complex subunits. Of note, PGC-1␣ is regulated not only at the mRNA level but also by posttranslational modifications such as phosphorylation and acetylation (4), meaning that a decrease in gene expression does not necessarily implicate that its transcriptional activity is switched off.
FoxO1 belongs to a subfamily of the forkhead transcription factors regulating a variety of biological processes, such as metabolism, cell proliferation and differentiation, and stress response (23, 25, 29) . FoxO1 is phosphorylated by active PKB, thereby causing its cytoplasmic sequestration through binding to the protein 14-3-3 (42) . Thus, in the absence of insulin/ growth factors, FoxO1 translocates to the nucleus, where it can trigger expression of specific genes. In our condition, we found that the total FoxO1 protein content was rapidly decreased in response to fasting, whereas the stoichiometry of phosphorylation of FoxO1 at Thr 24 , one of the residues phosphorylated directly by active PKB, was not affected. The transcription of FoxO1 was not affected in our condition (data not shown), meaning that the time-dependent decrease observed in FoxO1 should be due to change either in protein stability or in its subcellular localization. FoxO transcription factors are relatively stable proteins that are degraded in a proteasome-dependent manner, notably in response to insulin (3). Because plasma insulin levels are low during fasting, an increase in protein turnover is unlikely, rather suggesting a change in FoxO1 subcellular localization in favor of its nuclear retention. Interestingly, pyruvate dehydrogenase kinase-4 (PDK4), which is involved in the regulation of lipid metabolism and upregulated by fasting (Refs. 41 and 49 and our study), has been identified as a FoxO1 target gene in skeletal muscle (21) . Taken together, our finding suggests that the fasting-induced drop in plasma insulin levels might promote FoxO1 nuclear retention, leading to upregulation of FoxO1 target genes such as PDK4 and ultimately to enhanced skeletal muscle lipid oxidation. However, further studies, including extensive analysis of the subcellular localization of skeletal muscle FoxO isoforms in response to fasting, are required to strengthen this point.
Finally, the deacetylases SIRT1 and HDAC4 were recently shown to be involved in the metabolic shift toward lipid oxidation during fasting in peripheral tissues (22, 40) . For instance, SIRT1 can modulate metabolic processes in response to fasting through deacetylation of key transcription factors such as PGC-1␣ and FoxO1 (5). The nuclear translocation of SIRT1 and HDAC4, like FoxO1, has been shown to alter the expression of metabolic genes (19, 40, 55) . As mentioned above, the decrease in SIRT1 and HDAC4 protein content in response to fasting likely results from their nuclear translocation upon dephosphorylation. However, further studies are required to support this finding.
In the present study, we reported that more than 900 genes were altered in human skeletal muscle after 24 h of fasting, representing ϳ7% of the genes expressed in this tissue. However, only 23 genes, involved mostly in the regulation of metabolic processes, were found to be significantly affected by fasting at both early (10 h) and late (24 h) time points. Some of them have previously been reported to be upregulated (ANGPLT4, CITED2, PDK4, PFKFB3, TXNIP, and UCP3) or downregulated (SLC25A25) in response to fasting in human skeletal muscle and are likely contributing to the shift from glucose to lipid oxidation at the whole body level (33, 41, 49, 50) . In addition, we identified new candidate genes that are rapidly and consistently affected by fasting, suggesting that they might also play a role in the initial adaptation of skeletal muscle to energy deprivation. Unfortunately, few data are available on the functions of most of these genes, especially with respect to Genes are presented by hierarchical order. The whole set of significantly regulated genes can be found in the Supplemental Figure S1 . (2) . Interestingly, the expression of APLNR has been shown to be reduced in skeletal muscle from both high-fat-fed and db/db mice (17), whereas apelin treatment increases fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice (1). In addition, some genes involved in the cAMP (ARPP-21, PDE4D, PDE7A) or TGF␤ (TSC22D1, ZMIZ1) signaling pathways, which play crucial roles in the regulation of multiple cellular functions and physiological processes in skeletal muscle, were also found to be regulated by fasting. Clearly, additional studies are required to investigate whether these proteins are actually involved in the skeletal muscle metabolic adaptation to fasting and whether specific or common upstream pathways mediated their transcriptional regulation. Among the study limitations, it is worth mentioning that the study was initiated after an overnight fast with a standardized breakfast (t ϭ 0 min) containing ϳ15% of the average daily calorie intake. Therefore, it is conceivable that some nutrient-sensing pathways might not be fully activated by this moderate meal after 90 min (postmeal starting time point) and that effects of fasting on these pathways might have been partially blunted. Furthermore, we cannot exclude that part of the effects of fasting on signal transduction and/or protein/gene expression observed are specific to musculus vastus lateralis, which contains a mix of slow and fast fibers, and would have been different in muscles with other fiber type composition. In addition, the only pathway that was found to be significantly overrepresented in the two gene sets was the circadian clock after 10 h of fasting. Although very little is known in skeletal muscle, the core molecular clock plays an important role in the transcriptional regulation of metabolic processes (15) . Therefore, it is conceivable that some of the changes observed in gene expression can partly be secondary to circadian rhythms. Collectively, our study provides a comprehensive map of the main energy/nutrient-sensing pathways and transcriptomic changes during short-term adaptation to fasting in human skeletal muscle. Future studies are necessary to determine whether the observed changes are relevant in disease development as well as (healthy) aging and longevity.
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